読み込み中
NASDAQHealthcareMedical - Diagnostics & Research
最新データ
$15.78
−$0.03 · -0.19%
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome's first commercial-stage test, SimpleScreen CRC for colorectal cancer, is under review by the U.S. Food and Drug Administration (FDA).
前日終値
$15.78
−$0.03 · -0.19%
日中の時刻はETです。市場データは遅延する場合があります。
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome's first commercial-stage test, SimpleScreen CRC for colorectal cancer, is under review by the U.S. Food and Drug Administration (FDA).
日中レンジ
現在 $15.78
52週レンジ
現在 $15.78
日中の時刻はETです。市場データは遅延する場合があります。
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome's first commercial-stage test, SimpleScreen CRC for colorectal cancer, is under review by the U.S. Food and Drug Administration (FDA).
日中レンジ
現在 $15.78
52週レンジ
現在 $15.78
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$18.25
上昇余地（15.65%）この株式へのエクスポージャーを報告している上場投資信託です。
ARK Genomic Revolution ETFARKG1468.57万0.72%15.57億 USD0.75%$51.30+4.08%
Schwab U.S. Small-Cap ETFSCHA445.67万0.02%218.24億 USD0.03%$32.79+0.40%
iShares Core S&P Total U.S. Stock Market ETFITOT130.68万0.00%980.88億 USD0.03%$169.66+0.64%
Fidelity Nasdaq Composite Index ETFONEQ60.59万0.01%109.4億 USD0.21%$107.81+0.63%
Schwab U.S. Broad Market ETFSCHB52.14万0.00%453.77億 USD0.03%$29.91+0.61%
T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFTMED19.32万0.60%3296.48万 USD0.44%$33.8094+2.13%
T. Rowe Price Innovation Leaders ETFTNXT3.56万0.18%1966.95万 USD0.49%$29.155+1.22%
T. Rowe Price Small Cap ETFTSEE1.78万0.17%1048.05万 USD0.59%$24.6703+1.40%ARK Genomic Revolution ETFARKGSchwab U.S. Small-Cap ETFSCHAiShares Core S&P Total U.S. Stock Market ETFITOTFidelity Nasdaq Composite Index ETFONEQSchwab U.S. Broad Market ETFSCHBT. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFTMEDT. Rowe Price Innovation Leaders ETFTNXTT. Rowe Price Small Cap ETFTSEEAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
